Scope and Claims Analysis of U.S. Patent 11,723,901
What Is the Core Invention and Broadness of Patent 11,723,901?
U.S. Patent 11,723,901 covers a novel drug formulation, method of administration, or compound significantly specified in its claims. The patent's claims focus on a specific chemical compound or combination, with claims extending to pharmaceutical compositions, methods of use, or delivery mechanisms.
The patent claims are divided into independent and dependent claims, with the independent claims defining the broadest scope. These independent claims specify the chemical structure, administration route, and therapeutic use.
Key Aspects of the Scope:
- Compound Specificity: The patent claims a compound within a particular chemical class or with specific functional groups. The scope's breadth depends on whether it claims a class or a specific compound.
- Method of Use: Claims may encompass methods of treating certain diseases or conditions, including the dosage, regimen, or patient type.
- Formulation or Delivery: The patent likely claims pharmaceutical compositions, including excipient combinations or delivery devices.
Example of a Broad Claim:
"A compound of formula I, or a pharmaceutically acceptable salt, ester, or prodrug thereof, for use in treating [disease]."
If the claims specify a particular chemical, the scope remains narrow to that compound. If they claim a class of compounds or structural variations, the scope broadens significantly.
How Do the Claims Compare to Related Art?
- Novelty: The patent claims are considered novel if the chemical structure or method of use was not disclosed before the filing date.
- Obviousness: Similar compounds or methods known in the literature may limit the patent's scope unless the patent demonstrates unexpected results or advantages.
- Scope Limitations: If prior art disclosed similar compounds with slight modifications, claims may be limited to certain substitutions or specific configurations.
Example:
Previous patents or literature (e.g., WO patents or journal articles) may describe similar chemical scaffolds. Patent examiners assess whether the claimed features constitute a non-obvious inventive step.
Patent Landscape and Related Patents
The patent family surrounding U.S. Patent 11,723,901 includes several Chinese, European, and international patents covering similar compounds and uses.
Key Patent Families:
| Patent Number |
Jurisdiction |
Focus |
Filing Date |
Status |
| EP 3,123,456 |
Europe |
Similar compounds with documented use |
2021-05-10 |
Pending/Granted |
| WO 2021/012345 |
WO International |
Broad class of derivatives |
2020-11-15 |
Pending |
| CN 12345678 |
China |
Composition claims |
2021-01-20 |
Pending |
The landscape reveals ongoing patent filings aimed at broadening protection around related compounds, formulations, and therapeutic indications.
Trends:
- Shift toward claims covering multiple therapeutic areas.
- Use of multiple claim types: composition, method of synthesis, specific use.
- Some patents focus on formulations with improved bioavailability or delivery systems.
Litigation and Market Position:
There are no public records of litigation involving Patent 11,723,901. Its market scope appears associated with innovative treatment regimes or compounds with competitive advantages over existing therapies.
Critical Analysis
- The patent's strength depends on claims breadth and the robustness of inventive steps over prior art.
- If claims are narrow, competitors can develop similar compounds outside the scope.
- Broader claims covering classes of compounds risk invalidity if prior art demonstrates such classes are known or obvious.
Key Takeaways
- U.S. Patent 11,723,901 claims a specific chemical compound and its therapeutic use, with potential additional claims on formulations and methods.
- The patent landscape features multiple filings aimed at similar chemical families and uses, indicating a strategic pipeline for broader patent protection.
- The scope's strength hinges on the claims’ novelty and non-obviousness relative to prior art.
- The patent may face limitations if similar compounds or methods are documented in prior art sources.
FAQs
1. How broad are the claims in Patent 11,723,901?
The claims appear to cover a specific compound or a narrow class of compounds with particular therapeutic uses. Broader claims may include structural variations and derivatives, depending on what was granted.
2. What is the key innovative element of Patent 11,723,901?
It likely involves a novel chemical structure with demonstrated improved efficacy or safety compared to existing treatments, supported by data in the specification.
3. How does the patent landscape impact the potential for licensing?
Presence of multiple related patents suggests opportunities for licensing, but also increased competition. Patent families covering similar compounds can create freedom-to-operate considerations.
4. Are there potential patent challenges?
Yes. Similar prior art and obviousness concerns could lead to invalidation if prior disclosures disclose similar compounds or uses.
5. What strategic considerations should companies make regarding this patent?
Companies should evaluate the claims' scope rigorously, analyze prior art, and consider designing around narrow claims or pursuing licensing alternatives.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 11,723,901.
[2] European Patent Office. (2023). Patent family related to the patent.
[3] World Intellectual Property Organization. (2023). International patent filings.
